The Investigation of 2D Monolayers as Potential Chelation Agents in Alzheimer’s Disease

doi 10.7287/peerj.preprints.27942v3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

PeerJ

Related search

Commentary: The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer’s Disease

Frontiers in Neurology
Neurology
2017English

Filipin Levels as Potential Predictors of Alzheimer’s Disease Risk

Advances in Alzheimer's Disease
2014English

Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer’s Disease

Frontiers in Pharmacology
Pharmacology
2019English

Donepezil + Chromone + Melatonin Hybrids as Promising Agents for Alzheimer’s Disease Therapy

Journal of Enzyme Inhibition and Medicinal Chemistry
MedicineDrug DiscoveryPharmacology
2019English

Natural Compounds as Beneficial Antioxidant Agents in Neurodegenerative Disorders: A Focus on Alzheimer’s Disease

Antioxidants
BiochemistryClinical BiochemistryCell BiologyMolecular BiologyPhysiology
2019English

Anti-Hypertensive Agents in Alzheimer’s Disease: Beyond Vascular Protection

Expert Review of Neurotherapeutics
NeuroscienceNeurologyPharmacology
2019English

Derivatives of Piperazines as Potential Therapeutic Agents for Alzheimer's Disease

Molecular Pharmacology
Molecular MedicinePharmacology
2019English

Transition-Metal-Substituted Polyoxometalate Derivatives as Functional Anti-Amyloid Agents for Alzheimer’s Disease

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2014English

Synthesis and Application of Β-Carbolines as Novel Multi-Functional Anti-Alzheimer’s Disease Agents

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy